Peripartum cardiomyopathy (PPCM) is a possible life-threatening pregnancy-associated condition characterized by left ventricular (LV) dysfunction and heart failure (HF). Clinical findings of HF are sometimes obscured by normal physiological observed during pregnancy that renders the diagnosis complicated. Furthermore, postpartum hemorrhage followed by massive blood transfusion may mask the diagnosis of PPCM or worsen the decompensated HF The Risk factors for PPCM include multiparity, black ethnicity, older maternal age, preeclampsia, and gestational hypertension [1]. A case-control study in the United States showed that African American women had a 15.7-fold higher relative risk of PPCM than non – African Americans [2]. The prevalence of PPCM among black women was four times that of white women (1:1087 versus 1:4266), and the 5-year follow-up fatality risk was almost four times greater (24% versus 6%) [3]. The incidence of PPCM was 1 in 1741 deliveries in South Korea. There were 1.384.449 deliveries in South Korea between 2010 and 2012, despite removing 20.102 patients with previous suspected HF. Of these, 795 cases had codes that were specified as PPCM [4].